D1–D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum

We demonstrate a heteromeric D1–D2 dopamine receptor signaling complex in brain that is coupled to Gq/11 and requires agonist binding to both receptors for G protein activation and intracellular calcium release. The D1 agonist SKF83959 was identified as a specific agonist for the heteromer that activated Gq/11 by functioning as a full agonist for the D1 receptor and a high-affinity partial agonist for a pertussis toxin-resistant D2 receptor within the complex. We provide evidence that the D1–D2 signaling complex can be more readily detected in mice that are 8 months in age compared with animals that are 3 months old, suggesting that calcium signaling through the D1–D2 dopamine receptor complex is relevant for function in the postadolescent brain. Activation of Gq/11 through the heteromer increases levels of calcium/calmodulin-dependent protein kinase IIα in the nucleus accumbens, unlike activation of Gs/olf-coupled D1 receptors, indicating a mechanism by which D1–D2 dopamine receptor complexes may contribute to synaptic plasticity.

[1]  M. Constantine-Paton,et al.  NMDA receptor-mediated control of protein synthesis at developing synapses , 2000, Nature Neuroscience.

[2]  Alexei Verkhratsky,et al.  Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons. , 2005, Physiological reviews.

[3]  D. van der Kooy,et al.  Dopamine Specifically Inhibits Forebrain Neural Stem Cell Proliferation, Suggesting a Novel Effect of Antipsychotic Drugs , 2005, The Journal of Neuroscience.

[4]  I. Bezprozvanny,et al.  Dopamine Receptor-mediated Ca2+ Signaling in Striatal Medium Spiny Neurons* , 2004, Journal of Biological Chemistry.

[5]  B. O'dowd,et al.  D1 and D2 Dopamine Receptors Form Heterooligomers and Cointernalize after Selective Activation of Either Receptor , 2005, Molecular Pharmacology.

[6]  K. Fuxe,et al.  Adenosine A2A Receptor and Dopamine D3 Receptor Interactions: Evidence of Functional A2A/D3 Heteromeric Complexes , 2005, Molecular Pharmacology.

[7]  A. Graybiel,et al.  Concurrent Activation of Dopamine D1 and D2 Receptors Is Required to Evoke Neural and Behavioral Phenotypes of Cocaine Sensitization , 2002, The Journal of Neuroscience.

[8]  Martin H. Teicher,et al.  Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens. , 1995, Brain research. Developmental brain research.

[9]  H. Sarau,et al.  Evidence for a Distinct D1Like Dopamine Receptor that Couples to Activation of Phosphoinositide Metabolism in Brain , 1994, Journal of neurochemistry.

[10]  B. O'dowd,et al.  Dopamine D1 and D2 Receptor Co-activation Generates a Novel Phospholipase C-mediated Calcium Signal* , 2004, Journal of Biological Chemistry.

[11]  J. Lisman,et al.  The molecular basis of CaMKII function in synaptic and behavioural memory , 2002, Nature Reviews Neuroscience.

[12]  M. Lidow,et al.  Calcium signaling dysfunction in schizophrenia: a unifying approach , 2003, Brain Research Reviews.

[13]  Xuechu Zhen,et al.  Regulation of Cyclin-Dependent Kinase 5 and Calcium/Calmodulin-Dependent Protein Kinase II by Phosphatidylinositol-Linked Dopamine Receptor in Rat Brain , 2004, Molecular Pharmacology.

[14]  H Y Wang,et al.  Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation. , 1995, Molecular pharmacology.

[15]  Xuechu Zhen,et al.  SKF83959 selectively regulates phosphatidylinositol‐linked D1 dopamine receptors in rat brain , 2003, Journal of neurochemistry.

[16]  Takashi Kato,et al.  Age‐related changes of dopamine D1‐like and D2‐like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography , 2001, Synapse.

[17]  P. Kalivas,et al.  Calcium-mediated second messengers modulate the expression of behavioral sensitization to cocaine. , 1998, The Journal of pharmacology and experimental therapeutics.

[18]  Y. Lai,et al.  Photodynamic therapy for facial squamous cell carcinoma in cats using Photofrin. , 1998, Changgeng yi xue za zhi.

[19]  M. Taniguchi,et al.  A Novel Gαq/11-selective Inhibitor* , 2004, Journal of Biological Chemistry.

[20]  P. Seeman,et al.  Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Seamans,et al.  Dopamine Receptor Signaling , 2004, Journal of receptor and signal transduction research.